|
Real-time Estimate
Cboe Europe
04:07:54 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 8.900 CHF | +0.68% |
|
+4.00% | -62.94% |
| 10-22 | Newron Pharmaceuticals S.p.A. Completes Enrollment In Pivotal Phase 3 ENIGMA-TRS 1 Study | CI |
| 10-22 | Newron Pharmaceuticals Completes Enrollment for Schizophrenia Drug Late-stage Trial | MT |
Stock exchange
Swiss Exchange
NWRN 8.840 CHF
-1.56%
471K
CHF
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| NWRN | 8.840CHF | -1.56% | 471K CHF | ||
Xetra
| NP5 | 9.440EUR | -1.67% | 48.58K € | |
|
Tradegate
| NP5 | 9.380EUR | -2.09% | 469 € | |
|
CBOE
| 0QOI | 8.850CHF | +0.34% | 283.2 CHF | |
|
Deutsche Boerse AG
| NP5 | 9.360EUR | -1.27% | 0 € | |
|
Boerse Muenchen
| NP5 | 9.540EUR | +0.21% | 0 € | |
|
Börse Stuttgart
| NP5 | 9.540EUR | 0.00% | 0 € |
Quotes 5-day view: Newron Pharmaceuticals S.p.A.
Delayed Quote Swiss Exchange
| 2026-10-23 | 2026-10-26 | 2026-10-27 | 2026-10-28 | 2026-10-29 | |
|---|---|---|---|---|---|
| Last | CHF 8.640 | CHF 9.100 | CHF 8.980 | CHF 8.840 | CHF 8.840 |
| Volume | 35,077 | 61,599 | 50,546 | 53,306 | 53,306 |
| Change | -0.46% | +5.32% | -1.32% | -1.56% | +0.68% |
| Opening | CHF 8.680 | CHF 8.710 | CHF 9.200 | CHF 9.030 | CHF 9.030 |
| High | CHF 8.780 | CHF 9.190 | CHF 9.280 | CHF 9.230 | CHF 9.230 |
| Low | CHF 8.480 | CHF 8.640 | CHF 8.680 | CHF 8.730 | CHF 8.730 |
Performance
| 1 day | +0.68% | ||
| 1 week | +4.00% | ||
| Current month | +9.81% | ||
| 1 month | +16.01% | ||
| 3 months | -26.58% | ||
| 6 months | -41.38% | ||
| Current year | -62.94% | ||
| 1 year | -36.77% | ||
| 3 years | +84.17% | ||
| 5 years | +365.26% | ||
| 10 years | -54.67% |
Volumes
marketsDaily volume
53,306
Estimated daily volume
53,306
Avg. Volume 20 sessions
73,052
Daily volume ratio
0.73
Avg. Volume 20 sessions CHF
650,162.8
Avg. Volume 20 sessions USD
784,746.5
Record volume 1
2,869,218
Record volume 2
1,493,471
Record volume 3
1,445,697
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (CHF)
203,075,010
Market Cap (USD)
226,343,079
Net sales (EUR)
19,126,000
Net sales (USD)
21,317,432
Number of employees
27
Sales / Employee (EUR)
708,370
Sales / Employee (USD)
789,535
Free-Float
87.16%
Free-Float capitalization (CHF)
177,003,186
Free-Float capitalization (USD)
197,283,980
Average Daily Capital Traded
0.32%
Indicators
Moving average 5 days
8.848
Moving average 20 days
8.11
Moving average 50 days
10.14
Moving average 100 days
11.08
Price spread / (MMA5)
-0.58%
Price spread / (MMA20)
-8.87%
Price spread / (MMA50)
+13.97%
Price spread / (MMA100)
+24.49%
STIM
RSI 9 days
59.28
RSI 14 days
51.17
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.68% | +4.00% | -36.77% | +84.17% | 226M | |
| +0.65% | -3.36% | +36.98% | +60.50% | 64.14B | |
| +0.45% | +1.99% | +11.50% | +82.67% | 55.53B | |
| +0.54% | +0.99% | +10.45% | +100.19% | 53.03B | |
| +2.76% | +0.87% | +27.92% | +55.07% | 45.99B | |
| +2.00% | -3.39% | +17.83% | +119.04% | 42.45B | |
| +1.34% | -2.86% | +224.43% | +914.08% | 40.45B | |
| +0.64% | -3.95% | +11.15% | +45.57% | 32.25B | |
| -5.05% | +47.63% | +107.12% | +92.73% | 34.47B | |
| -2.85% | -0.57% | +23.02% | -10.89% | 24.23B | |
| Average | +0.13% | +4.07% | +43.36% | +154.31% | 39.28B | |
| Weighted average by Cap. | +0.36% | +3.49% | +49.10% | +159.80% |
Historical Quotes: Newron Pharmaceuticals S.p.A.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 8.48 |  | 9.28 |
| 1 month | 5.72 | | 9.28 |
| Current year | 5.72 | | 31.85 |
| 1 year | 5.72 | | 31.85 |
| 3 years | 4.09 | | 31.85 |
| 5 years | 1.01 | | 31.85 |
| 10 years | 0.9 | | 31.85 |
Monthly variations
Annual variations
| 2026 | -62.94% | ||
| 2025 | +166.48% | ||
| 2024 | +80.81% | ||
| 2023 | +219.35% | ||
| 2022 | -4.32% | ||
| 2021 | -24.65% | ||
| 2020 | -66.14% | ||
| 2019 | +13.19% | ||
| 2018 | -51.64% | ||
| 2017 | -42.43% | ||
| 2016 | -21.29% | ||
| 2015 | -2.29% | ||
| 2014 | +55.95% | ||
| 2013 | +108.96% | ||
| 2012 | +265.45% | ||
| 2011 | -61.27% | ||
| 2010 | -69.63% | ||
| 2009 | +34.53% | ||
| 2008 | -72.75% | ||
| 2007 | -4.32% | ||
| 2006 | +0.38% |
- Stock Market
- Stocks
- NWRN Stock
- Quotes Newron Pharmaceuticals S.p.A.
Select your edition
All financial news and data tailored to specific country editions
